Skip to content

DRCAVEZRX

Active Private limited companyfounded 2019active for 7 yearsJan Baptist Denayerstraat 46, 1560 HoeilaartKBO/BCE: BE 0721.721.273

Lifetime

7 annual accounts with figures on one time axis
peak of €347,358 in 2023
€333,541▲ 6.5%
peak of €249,827 in 2023
€249,379▲ 9.4%
peak of €340,168 in 2021
€18,600▼ 85.6%
€263,617▲ 112%
Board1 name since 2019
1 director
Documentsfilings and deeds
15-07-202616 days before the deadline
2025micro format
Dividend €359,750Equity from €128,971 to €18,600Debts from €124,097 to €263,617

Key points

from the 2025 annual accounts

Equity

€18,600 from €340,168 in 2021

Equity fell by 95% in 4 years.

Turnover

≈ €670,000 estimated

The micro format states no turnover.

Debts

€263,617 93% of the balance sheet
Suppliers 0%Taxes and wages 15%Other 84%

Liquidity

0.98 was 1.81 in 2024

Short-term debts rose from €124,097 to €263,617.

Filings

7 annual accounts 4 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came in latest, 87 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as DRCAVEZRX has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for DRCAVEZRX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 28-02-2019
  • 100 sharesdeed of 04-03-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0721721273
New director appointed, resigned · Discharge granted to · Gazette deed
Registered office moved within Hoeilaart The registered office moved from Terdellestraat 4, 1560 Hoeilaart to Jan Baptist Denayerstraat 46, 1560 Hoeilaart · acts as permanent representative · Board meeting of 26-04-2022 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares · Founded by (comparant) · appointed as manager · published on 04-03-2019 · Gazette deed
All 16 events

Official details

Source: KBO
Status
Active since 28-02-2019Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other2 activities on the establishment unitFrom the articles, 11 activities
Establishment unit
2.290.278.5791560 Hoeilaart, since 28-02-2019
Financial year end
31 December
Peppol
Reachable since 08-02-2026
Company details

Annual accounts 2025

€282,217▲ 11.5%
Filing
Filed on 15-07-2026, 16 days before the end of the filing period
Financials

Insights on DRCAVEZRX

DRCAVEZRX files the micro format. That format states no turnover. The gross margin rose from €201,788 in 2019 to €333,541 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DRCAVEZRX

What is the company number of DRCAVEZRX?
The company number of DRCAVEZRX is 0721.721.273. The VAT number is the same number with BE in front: BE 0721.721.273.
Where is DRCAVEZRX based?
The registered office is at Jan Baptist Denayerstraat 46, 1560 Hoeilaart.Company details
What does DRCAVEZRX do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220). The KBO lists 1 more.
What is the legal form of DRCAVEZRX?
DRCAVEZRX is a private limited company (BV).
When was DRCAVEZRX founded?
DRCAVEZRX was founded on 28-02-2019.
Is DRCAVEZRX still active?
Yes, DRCAVEZRX is an active enterprise in the KBO register.
What is the turnover of DRCAVEZRX?
The turnover in financial year 2025 is about €670,000. This figure is estimated from the gross margin of €333,541 and 1,019 comparable companies of the same size. It probably lies between €470,000 and €980,000. It is a rough estimate.Financials
Is DRCAVEZRX profitable?
In financial year 2025, DRCAVEZRX made a profit of €249,379.
Where can I find the annual accounts of DRCAVEZRX?
DRCAVEZRX filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DRCAVEZRX due?
DRCAVEZRX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.